PharmaGazette: June 2008 Archives

« May 2008 | Main | July 2008 »

Jun30	Happy Canada Day L. Lewis June 30, 2008 Know More: Author Profile Being a proud Canadian tomorrow is a big day for me. Yup, it's Canada's birthday. There will be fireworks displays across the country and just about every little town and big city will be having festvities. To my fellow Canadian readers: To Canada: Happy 141st Birthday For those of you that don't know where Canada is here's a map ;) Posted at 6:00 PM \| Permalink \| Comments
Jun30	Stock Market Fluctuations in Big Pharmas as of June 30, 2008 L. Lewis June 30, 2008 Company Name, Symbol, Share Price, Change Abbott Laboratories' (NYSE:ABT) - $52.97 -0.03 (-0.06%) AstraZeneca (NYSE:AZN) - $42.53 +0.78 (+1.87%) Bristol-Myers Squibb (NYSE:BMY) - $20.53 +0.23 (+1.13%) Eli Lilly & Co. (NYSE:LLY) - $46.16 +0.55 (+1.21%) GlaxoSmithKline(NYSE:GSK) - $44.22 +0.24 (+0.55) Merck & Co. (NYSE:MRK) -... Continue Reading Posted at 3:00 PM \| Permalink \| Comments
	GSK Answers FDA on Cervarix L. Lewis June 30, 2008 GlaxoSmithKline (NYSE:GSK) announced that it has submitted its response to the U.S. Food and Drug Administration to questions the agency had in response to GSK's drug application for Cervarix.Cervarix, a vaccine for the prevention of cervical cancer, one of the largest drug... Continue Reading Posted at 12:00 PM \| Permalink \| Comments
	BlogWorld Expo 2008 L. Lewis June 30, 2008 KnowMoreMedia is proud to announce our partnership and sponsorship of BlogWorld Expo 2008. This is the 2nd annual BlogWorld Expo and it is being held Sept 20 - 21 at the Las Vegas Convention Center.BlogWorld Expo is the world's largest... Continue Reading Posted at 10:00 AM \| Permalink \| Comments
Jun27	Interesting Articles for Week of June 27, 2008 L. Lewis June 27, 2008 Another active week in pharmacology and health news. These are some stories that didn't get covered this week at Pharmagazette. Topics range from Cancer and Alzheimer's to the increase in diabetes patients in the U.S and colorectal cancer. Each is... Continue Reading Posted at 5:00 PM \| Permalink \| Comments
Jun25	FDA Approves Combo Vaccine, Kinrix, for Kids L. Lewis June 25, 2008 The U.S. Food and Drug Administration has approved GlaxoSmithKline's combination booster vaccine, Kinrix.Kinrix protects children between 4 and 6 years old against diphtheria, pertussis, polio and tetanus and is approved for children who previously received GSK's Infanrix, which covers diptheria,... Continue Reading Posted at 12:00 PM \| Permalink \| Comments
	FDA Delays Prasugrel Approval 3 Months L. Lewis June 25, 2008 Eli Lilly & Co and Daiichi Sankyo announced the U.S. Food and Drug Administration had extended the period of review by three months for their anti-clotting drug, Prasugrel.Prasugrel received priority review status from the FDA in February based on studies that... Continue Reading Posted at 11:00 AM \| Permalink \| Comments
	DOJ Investigation of Paxil Widens L. Lewis June 25, 2008 The U.S. Department of Justice confirmed that its investigation into whether GlaxoSmithKline withheld data concerning adverse risk associated with Paxil has been expanded to include the U.S. attorney's office in Boston and is being coordinated in Washington.Paxil, an antidepressant drug... Continue Reading Posted at 9:00 AM \| Permalink \| Comments
	Gardasil Gets FDA Non-Approval for Expanded Use L. Lewis June 25, 2008 Merck & Co. (NYSE:MRK) announced that the U.S. Food and Drug Administration did not approve the company's application to expand the use of Gardasil to include women between the ages of 27 and 45.Gardasil, a cervical cancer vaccine, was previously... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun24	FDA Approves Cymbalta for Fibromyalgia L. Lewis June 24, 2008 Eli Lilly & Co. (NYSE:LLY) announced that it has received U.S. Food and Drug Administration approval for Cymbalta for the management of fibromyalgia, a chronic pain disorder.Cymbalta (duloxetine HCl) is the first serotonin-norepinephrine reuptake inhibitor that has proven effective in the... Continue Reading Posted at 11:00 AM \| Permalink \| Comments
	Fibromyalgia L. Lewis June 24, 2008 Fibromyalgia is a chronic illness whose symptoms include widespread pain in the muscles, ligaments and tendons. It is also characterized by fatigue and multiple tender points.The illness is more common in women than in men but it is not progressive... Continue Reading Posted at 9:00 AM \| Permalink \| Comments
	Avodart FDA Approved for Symptomatic Enlarged Prostate L. Lewis June 24, 2008 The U.S. Food and Drug Administration has approved GlaxoSmithKline(NYSE:GSK) Avodart in combination with tamsulosin for the treatment of symptomatic enlarged prostate.Enlarged prostate is a disease that affects 50% of men over the age of 50 and 90% of men over... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun23	Alcoholics’ Quality of Life Improves with Topiramate L. Lewis June 23, 2008 A new study conducted by Dr Bankole A. Johnson of the University of Virginia has found that topiramate not only helps decrease alcohol dependency but also improves alcoholics’ quality of life. Topiramate, brand name Topamax, is an anti-seizure medication that... Continue Reading Posted at 12:00 PM \| Permalink \| Comments
Jun20	"Virtual Man" May Reduce Drug Testing Time L. Lewis June 20, 2008 Reuters is reporting on developing technology that may help pharmaceutical manufacturers reduce the research cost and time currently required for the testing of new drugs.New computing technologies which have developed "Virtual Man" (virtual physiological human or VPH) may be able... Continue Reading Posted at 11:00 AM \| Permalink \| Comments
	E-Prescription for Controlled Drugs Coming Soon L. Lewis June 20, 2008 The U.S. Drug Enforcement Agency stated that U.S. drug regulators are close to permitting doctors to prescribe controlled drugs electronically rather than requiring only a written prescription.Recent studies have found that while the new rules would make it easier for... Continue Reading Posted at 10:00 AM \| Permalink \| Comments
	Interesting Articles for Week of June 20, 2008 L. Lewis June 20, 2008 It's been and interesting and diverse week in the field of pharmaceuticals and health with articles that cover a broad range of topics.Here are some of the ones that I found more intesesting and informative:Researchers ID Traits of Aggressive Prostate... Continue Reading Posted at 9:00 AM \| Permalink \| Comments
Jun18	FDA Adds Black Box Warning to Older Class of Antipsychotic Drugs L. Lewis June 18, 2008 The U.S. Food and Drug Administration announced that it now requires the manufacturers of "conventional" antipsychotic drugs to include a black box warning on the labeling and prescribing information of this class of drugs.The changes are to warn about an increased... Continue Reading Posted at 9:00 AM \| Permalink \| Comments
Jun17	Know More Media Reader Survey L. Lewis June 17, 2008 Hi Everyone!I'm sure you've all noticed the BIG BLUE box just above the entries on this website. The box right below the site header "Pharma Gazette". It alternates between "Help This Blog", "Quick Readership Survey" and "Complete a Quick Readership Survey".(yup, that... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun16	Diabetes: Causes, Cures and Prevention L. Lewis June 16, 2008 Of the estimated 20.8 million people in the U.S that have diabetes, 6.2 million people are undiagnosed and unaware. Could you be one of them?Type 1 DiabetesType 1 diabetes is usually diagnosed in children and young adults. It is the... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun11	FDA Adds Warning to Regranex L. Lewis June 11, 2008 Johnson & Johnson's foot ulcer medication, Regranex, has had a U.S. Food and Drug Administration warning added to its label stating that using large amounts of the cream could increase the risk of cancer.The warning, the FDA's strongest, states that... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun 6	Naltrexone Decreases Urge to Gamble L. Lewis June 6, 2008 A new study released by Dr. Jon E. Grant of the University of Minnesota in Minneapolis and his colleagues has found that the urge to gamble was decreased in pathological gamblers who were treated with naltrexone.Naltrexone, a drug frequently used... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun 5	Humira, Remicade and Enbrel Under FDA Review for Cancer Link L. Lewis June 5, 2008 The U.S. Food and Drug Administration announced that it is investigating whether a group of arthritis drugs increase the risk of pediatric cancer. The group of drugs include Abbott Laboratories' Humira, Schering-Plough's Remicade and Enbrel by Amgen and Wyeth.The FDA... Continue Reading Posted at 6:00 AM \| Permalink \| Comments
Jun 3	Istradfeylline May Cut Parkinson's Tremors L. Lewis June 3, 2008 A new study by Dr Mark Stacey of Duke University Medical Center found that Istradfeylline may help Parkinson's patients fight the spasms, tremors and tics they experience when their main medications wear off.Many Parkinson's patients experience a "wearing off" of... Continue Reading Posted at 10:00 AM \| Permalink \| Comments
	Lorenzo Odone Dies at Age 30 L. Lewis June 3, 2008 Gloria Gamat published an article in February 2007 about the movie "Lorenzo's Oil."The movie described the heroic crusade of Augusto and Michaela Odone to find a cure for their son's, Lorenzo Michael Murphy Odone, illness. Lorenzo suffered from the rare... Continue Reading Posted at 9:00 AM \| Permalink \| Comments

« May 2008 | Main | July 2008 »

Jun30	Happy Canada Day L. Lewis June 30, 2008 Know More: Author Profile Being a proud Canadian tomorrow is a big day for me. Yup, it's Canada's birthday. There will be fireworks displays across the country and just about every little town and big city will be having festvities. To my fellow Canadian readers: To Canada: Happy 141st Birthday For those of you that don't know where Canada is here's a map ;) Posted at 6:00 PM \| Permalink \| Comments
Jun30	Stock Market Fluctuations in Big Pharmas as of June 30, 2008 L. Lewis June 30, 2008 Company Name, Symbol, Share Price, Change Abbott Laboratories' (NYSE:ABT) - $52.97 -0.03 (-0.06%) AstraZeneca (NYSE:AZN) - $42.53 +0.78 (+1.87%) Bristol-Myers Squibb (NYSE:BMY) - $20.53 +0.23 (+1.13%) Eli Lilly & Co. (NYSE:LLY) - $46.16 +0.55 (+1.21%) GlaxoSmithKline(NYSE:GSK) - $44.22 +0.24 (+0.55) Merck & Co. (NYSE:MRK) -... Continue Reading Posted at 3:00 PM \| Permalink \| Comments
	GSK Answers FDA on Cervarix L. Lewis June 30, 2008 GlaxoSmithKline (NYSE:GSK) announced that it has submitted its response to the U.S. Food and Drug Administration to questions the agency had in response to GSK's drug application for Cervarix.Cervarix, a vaccine for the prevention of cervical cancer, one of the largest drug... Continue Reading Posted at 12:00 PM \| Permalink \| Comments
	BlogWorld Expo 2008 L. Lewis June 30, 2008 KnowMoreMedia is proud to announce our partnership and sponsorship of BlogWorld Expo 2008. This is the 2nd annual BlogWorld Expo and it is being held Sept 20 - 21 at the Las Vegas Convention Center.BlogWorld Expo is the world's largest... Continue Reading Posted at 10:00 AM \| Permalink \| Comments
Jun27	Interesting Articles for Week of June 27, 2008 L. Lewis June 27, 2008 Another active week in pharmacology and health news. These are some stories that didn't get covered this week at Pharmagazette. Topics range from Cancer and Alzheimer's to the increase in diabetes patients in the U.S and colorectal cancer. Each is... Continue Reading Posted at 5:00 PM \| Permalink \| Comments
Jun25	FDA Approves Combo Vaccine, Kinrix, for Kids L. Lewis June 25, 2008 The U.S. Food and Drug Administration has approved GlaxoSmithKline's combination booster vaccine, Kinrix.Kinrix protects children between 4 and 6 years old against diphtheria, pertussis, polio and tetanus and is approved for children who previously received GSK's Infanrix, which covers diptheria,... Continue Reading Posted at 12:00 PM \| Permalink \| Comments
	FDA Delays Prasugrel Approval 3 Months L. Lewis June 25, 2008 Eli Lilly & Co and Daiichi Sankyo announced the U.S. Food and Drug Administration had extended the period of review by three months for their anti-clotting drug, Prasugrel.Prasugrel received priority review status from the FDA in February based on studies that... Continue Reading Posted at 11:00 AM \| Permalink \| Comments
	DOJ Investigation of Paxil Widens L. Lewis June 25, 2008 The U.S. Department of Justice confirmed that its investigation into whether GlaxoSmithKline withheld data concerning adverse risk associated with Paxil has been expanded to include the U.S. attorney's office in Boston and is being coordinated in Washington.Paxil, an antidepressant drug... Continue Reading Posted at 9:00 AM \| Permalink \| Comments
	Gardasil Gets FDA Non-Approval for Expanded Use L. Lewis June 25, 2008 Merck & Co. (NYSE:MRK) announced that the U.S. Food and Drug Administration did not approve the company's application to expand the use of Gardasil to include women between the ages of 27 and 45.Gardasil, a cervical cancer vaccine, was previously... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun24	FDA Approves Cymbalta for Fibromyalgia L. Lewis June 24, 2008 Eli Lilly & Co. (NYSE:LLY) announced that it has received U.S. Food and Drug Administration approval for Cymbalta for the management of fibromyalgia, a chronic pain disorder.Cymbalta (duloxetine HCl) is the first serotonin-norepinephrine reuptake inhibitor that has proven effective in the... Continue Reading Posted at 11:00 AM \| Permalink \| Comments
	Fibromyalgia L. Lewis June 24, 2008 Fibromyalgia is a chronic illness whose symptoms include widespread pain in the muscles, ligaments and tendons. It is also characterized by fatigue and multiple tender points.The illness is more common in women than in men but it is not progressive... Continue Reading Posted at 9:00 AM \| Permalink \| Comments
	Avodart FDA Approved for Symptomatic Enlarged Prostate L. Lewis June 24, 2008 The U.S. Food and Drug Administration has approved GlaxoSmithKline(NYSE:GSK) Avodart in combination with tamsulosin for the treatment of symptomatic enlarged prostate.Enlarged prostate is a disease that affects 50% of men over the age of 50 and 90% of men over... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun23	Alcoholics’ Quality of Life Improves with Topiramate L. Lewis June 23, 2008 A new study conducted by Dr Bankole A. Johnson of the University of Virginia has found that topiramate not only helps decrease alcohol dependency but also improves alcoholics’ quality of life. Topiramate, brand name Topamax, is an anti-seizure medication that... Continue Reading Posted at 12:00 PM \| Permalink \| Comments
Jun20	"Virtual Man" May Reduce Drug Testing Time L. Lewis June 20, 2008 Reuters is reporting on developing technology that may help pharmaceutical manufacturers reduce the research cost and time currently required for the testing of new drugs.New computing technologies which have developed "Virtual Man" (virtual physiological human or VPH) may be able... Continue Reading Posted at 11:00 AM \| Permalink \| Comments
	E-Prescription for Controlled Drugs Coming Soon L. Lewis June 20, 2008 The U.S. Drug Enforcement Agency stated that U.S. drug regulators are close to permitting doctors to prescribe controlled drugs electronically rather than requiring only a written prescription.Recent studies have found that while the new rules would make it easier for... Continue Reading Posted at 10:00 AM \| Permalink \| Comments
	Interesting Articles for Week of June 20, 2008 L. Lewis June 20, 2008 It's been and interesting and diverse week in the field of pharmaceuticals and health with articles that cover a broad range of topics.Here are some of the ones that I found more intesesting and informative:Researchers ID Traits of Aggressive Prostate... Continue Reading Posted at 9:00 AM \| Permalink \| Comments
Jun18	FDA Adds Black Box Warning to Older Class of Antipsychotic Drugs L. Lewis June 18, 2008 The U.S. Food and Drug Administration announced that it now requires the manufacturers of "conventional" antipsychotic drugs to include a black box warning on the labeling and prescribing information of this class of drugs.The changes are to warn about an increased... Continue Reading Posted at 9:00 AM \| Permalink \| Comments
Jun17	Know More Media Reader Survey L. Lewis June 17, 2008 Hi Everyone!I'm sure you've all noticed the BIG BLUE box just above the entries on this website. The box right below the site header "Pharma Gazette". It alternates between "Help This Blog", "Quick Readership Survey" and "Complete a Quick Readership Survey".(yup, that... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun16	Diabetes: Causes, Cures and Prevention L. Lewis June 16, 2008 Of the estimated 20.8 million people in the U.S that have diabetes, 6.2 million people are undiagnosed and unaware. Could you be one of them?Type 1 DiabetesType 1 diabetes is usually diagnosed in children and young adults. It is the... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun11	FDA Adds Warning to Regranex L. Lewis June 11, 2008 Johnson & Johnson's foot ulcer medication, Regranex, has had a U.S. Food and Drug Administration warning added to its label stating that using large amounts of the cream could increase the risk of cancer.The warning, the FDA's strongest, states that... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun 6	Naltrexone Decreases Urge to Gamble L. Lewis June 6, 2008 A new study released by Dr. Jon E. Grant of the University of Minnesota in Minneapolis and his colleagues has found that the urge to gamble was decreased in pathological gamblers who were treated with naltrexone.Naltrexone, a drug frequently used... Continue Reading Posted at 8:00 AM \| Permalink \| Comments
Jun 5	Humira, Remicade and Enbrel Under FDA Review for Cancer Link L. Lewis June 5, 2008 The U.S. Food and Drug Administration announced that it is investigating whether a group of arthritis drugs increase the risk of pediatric cancer. The group of drugs include Abbott Laboratories' Humira, Schering-Plough's Remicade and Enbrel by Amgen and Wyeth.The FDA... Continue Reading Posted at 6:00 AM \| Permalink \| Comments
Jun 3	Istradfeylline May Cut Parkinson's Tremors L. Lewis June 3, 2008 A new study by Dr Mark Stacey of Duke University Medical Center found that Istradfeylline may help Parkinson's patients fight the spasms, tremors and tics they experience when their main medications wear off.Many Parkinson's patients experience a "wearing off" of... Continue Reading Posted at 10:00 AM \| Permalink \| Comments
	Lorenzo Odone Dies at Age 30 L. Lewis June 3, 2008 Gloria Gamat published an article in February 2007 about the movie "Lorenzo's Oil."The movie described the heroic crusade of Augusto and Michaela Odone to find a cure for their son's, Lorenzo Michael Murphy Odone, illness. Lorenzo suffered from the rare... Continue Reading Posted at 9:00 AM \| Permalink \| Comments

Pharmaceutical Industry discussion, review, analysis, news and information.

Advertise

Related Resources

recent comments

sponsored ads

topics

subscribe

Current News

resources

Support This Blog

archives

blogroll

business social media

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

we support unitus

PRWeb

Influencer

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb